Riina Bray

Dr. Riina Bray

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2024 in JMIR Formative Research
Verified
Journal Article
Open access
RBRiina Bray
Riina Bray
YWYifan Wang
Yifan Wang
NANikolas Argiropoulos
Nikolas Argiropoulos
SRStephanie Robins
Stephanie Robins
JMJohn Mark Molot
John Mark Molot
RPRohini Lucy Peris
Rohini Lucy Peris
Background: Multiple chemical sensitivity (MCS) develops in response to repeated small-level chemical exposures or a major exposure in a subset of people, who then experience symptoms that can range from mild to debilitating when exposed to chemicals. The arrival of the COVID-19 pandemic and the stringent health measures put in place may have increased the burden for those living with MCS, as it became more challenging to avoid chemicals that trigger their condition. Objective: This study aimed to better understand the lived experience of Canadians living with MCS during the first year of the COVID-19 pandemic. Methods: An online questionnaire was created to ask participants to compare daily living during the pandemic to before March 11, 2020. Data were collected in January and February 2021. Three areas were investigated: (1) environmental exposures to chemical triggers from ambient air (pollution from industry, farming, and traffic) and indoor air (the smell of cleaning products, cooking odors, and smoke); (2) access to, and satisfaction with, health care visits; and (3) how people experiencing MCS rated contact with their social network. Results: In all, 119 Canadians who had lived with MCS for more than a year completed the questionnaire. The participant sample was mostly female (86.6%, n=103) and highly educated, with 57.1% (n=68) having a university degree. Slightly more than half (57.1%, n=68) were older than 55 years. McNemar chi-square and Wilcoxon signed rank tests were used to evaluate if there were statistically significant changes before (“prepandemic period”) and after (“postpandemic period”) March 11, 2020. Perceived exposure to pollution from a highway or a road was significantly decreased from the prepandemic to postpandemic period (z=–3.347; P<.001). Analysis of industry or power plants also suggested a significant decrease in the perceived exposure from the prepandemic to postpandemic period (z=–2.152; P=.04). Participants reported an increase in exposure to odors from disinfectants or sanitizers that entered their living environment (P<.001). There was a significant decrease between prepandemic and postpandemic levels of satisfaction when attending in-person meetings with a physician (z=–2.048; P=.04), yet there were no significant differences between prepandemic and postpandemic levels of satisfaction for online or telephone meetings with a physician. Although people with MCS experienced increased social isolation (P<.001), they also reported an increase in understanding from family (P=.03) and a decrease in stigma for wearing personal protective equipment (P<.001). Conclusions: During the first year of the COVID-19 pandemic, people with MCS were impacted by inaccessibility, loss of social support, and barriers to accessing health care. This study highlights unique challenges and possible benefits associated with the COVID-19 pandemic public health measures for individuals living with MCS. These findings can guide decision makers to improve policies on accessibility through appropriate accommodation measures.

9 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Nene Aïssatou DialloNene Aïssatou Diallo
Nene Aïssatou Diallo
JMJohn Mark Molot
John Mark Molot
RBRiina Bray
Riina Bray
ATAdrianna Trifunovski
Adrianna Trifunovski
RPRohini Lucy Peris
Rohini Lucy Peris
Multiple chemical sensitivity (MCS) is a chronic condition characterized by adverse multisystem reactions including to low-level chemical exposures. The use of fragranced and disinfectant products within healthcare institutions was frequently reported by individuals with MCS as a challenge to accessing healthcare. This study was conducted during the COVID-19 pandemic, when the use of infection control measures may have intensified the pre-existing barriers. This study examines how adults with MCS in Canada experience access to healthcare (such as access to diagnosis, physicians, and satisfaction with in-person and virtual care). A national cross-sectional survey was conducted between January and February 2021 among adults living with MCS for at least one year prior to the pandemic. Quantitative and open-ended questions captured experiences related to diagnosis, access to physicians, and satisfaction with virtual and in-person healthcare. Of the 119 participants who completed the survey, most reported having a formal diagnosis of MCS (78%). Among those who could not obtain an MCS diagnosis, common barriers included obtaining any other diagnosis but MCS (62%), and the belief among medical professionals that MCS does not exist (58%). In virtual care, dissatisfaction was primarily driven by a lack of understanding of the condition (43%). Dissatisfaction with in-person care was similarly attributed to a lack of understanding of the condition (21%) and exposure to cleaning and disinfection products (21%). Pandemic-related public health responses intensified pre-existing barriers to care for people with MCS by increasing chemical exposures and constraining access to knowledgeable providers. These findings highlight the need for healthcare systems and emergency preparedness frameworks that integrate chemical safety, disability inclusion, and provider education to ensure equitable access, including during public health crises.

9 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ATAdrianna Trifunovski
Adrianna Trifunovski
RLRoberto Lattanzio
Roberto Lattanzio
JMJohn Mark Molot
John Mark Molot
RBRiina Bray
Riina Bray
Caroline BarakatCaroline Barakat
Caroline Barakat
RPRohini Lucy Peris
Rohini Lucy Peris
Indoor air quality (IAQ) is an important determinant of public health, especially for individuals with multiple chemical sensitivity (MCS). Fragrances emit volatile organic compounds (VOCs) that can contribute to poor IAQ. Although scent-free policies are being widely implemented as an accommodation for those impacted by fragrances, their ability to improve IAQ has not been examined. This study assessed if scent-free policies can improve IAQ across Canadian offices. IAQ testing was conducted between December 2023 and June 2024 in 34 offices (17 with scent-free policies, 17 without). Sampling included total VOCs (TVOCs), top 35 VOCs, formaldehyde, CO, CO₂, PM₂.₅, temperature, and relative humidity. Analyses controlled for room size, occupancy, and ventilation rate using Mann-Whitney U tests and generalized linear models. Regression analysis revealed significantly higher VOC concentrations in spaces without scent-free policies, including acetaldehyde (OR = 2.2, p <.05), acetone (OR = 7.7, p <.001), toluene (OR = 3.4, p <0.05), m-/p-xylene (OR = 6.9, p <.001), o-Xylene (OR = 15.5, p <.001), and TVOCs (ORs = 3.9, p<.001). This study provides findings that support scent-free policies as a low-cost source control strategy to help lower VOC concentrations and improve IAQ accessibility.

14 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Nene Aïssatou DialloNene Aïssatou Diallo
Nene Aïssatou Diallo
JMJohn Mark Molot
John Mark Molot
RBRiina Bray
Riina Bray
ATAdrianna Trifunovski
Adrianna Trifunovski
RPRohini Lucy Peris
Rohini Lucy Peris
Multiple Chemical Sensitivity (MCS) is a chronic condition characterized by adverse reactions on exposure to low-level environmental chemical exposures, often resulting in multisystem symptoms triggered by substances such as volatile organic compounds (VOCs) from fragranced personal and household products. The condition emerges as public health and accessibility issues, as people with MCS may face barriers to accessing workplaces, healthcare settings, educational institutions, and other public environments. This study aims to describe the chemical exposures associated with the onset of the condition (sensitization) and subsequent symptom provocation in MCS, and to characterize symptom patterns and links with known transient receptor potential (TRP) receptor sensitization models. A cross-sectional survey was administered to Canadian residents aged 18 years or older, living with MCS for at least 1 year, with 18 questions assessing exposure history and associations with onset of MCS and symptom provocation. A total of 119 participants completed the survey. Condition onset often occurred at home (35%) and/or in the workplace (55%), following ongoing exposures (61%). Scents, such as perfumes and/or essential oils, including scented air fresheners, cleaning products, construction materials, disinfectants, and laundry products, were associated with both onset and subsequent symptom triggering. Symptoms involved multiple organ systems, with nearly one-third of participants reporting 11 or more symptoms. Cognitive and respiratory symptoms were most prevalent. Third-hand exposure may represent an underrecognized exposure pathway.

14 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Nene Aïssatou DialloNene Aïssatou Diallo
Nene Aïssatou Diallo
JMJohn Mark Molot
John Mark Molot
RBRiina Bray
Riina Bray
ATAdrianna Trifunovski
Adrianna Trifunovski
RPRohini Lucy Peris
Rohini Lucy Peris
Background: Multiple chemical sensitivity (MCS), a recognized disability, is a chronic, multisystem condition in which exposure to common chemical substances provokes adverse health effects and functional impairment. Although population-level data and emerging clinical research support the pathophysiological basis of MCS, individuals living with the condition frequently encounter barriers to recognition and accommodation across employment, healthcare, and housing systems. This study examines patterns of accommodation requests, refusals, and associated socioeconomic impacts among adults living with MCS in Canada, with particular attention to how institutional recognition shapes access to supports. A national cross-sectional survey of 119 Canadian adults living with MCS was conducted between January and February 2021. Quantitative data were analyzed descriptively to assess accommodation requests, outcomes, employment status, income, and housing stability. Qualitative responses were analyzed thematically to contextualize participants’ experiences of disclosure, denial, and exclusion. Participants were predominantly female (87%) with post-secondary education (90%). Among participants who reported being unemployed (29%), 94% attributed it primarily to MCS-related limitations. Accommodation denial was common: 85% of respondents reported requesting accommodations, and 78% of those experienced refusals. On housing conditions, 52% reported living in unsafe housing (defined as housing with the presence of mould or symptom-triggering exposures), while 17% reported being homeless (e.g., moving frequently, personal vehicle, tent). The findings indicate that the lack of institutional recognition of MCS functions as a structural barrier to accommodation, contributing to health, economic, and social inequities. Addressing these barriers requires accommodation frameworks that prioritize functional accessibility and inclusion across employment and housing contexts.

10 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
SRSudipta Roy
Sudipta Roy
JMJohn Mark Molot
John Mark Molot
RLRoberto Lattanzio
Roberto Lattanzio
RBRiina Bray
Riina Bray
JAJennifer Armstrong
Jennifer Armstrong
RPRohini Lucy Peris
Rohini Lucy Peris
Background: Indoor air quality (IAQ) is increasingly recognized as a key yet overlooked public health determinant. Fragranced consumer products can contribute to indoor air pollution and trigger adverse health effects in sensitive individuals. Despite the increasing adoption of fragrance-free policies across institutions, substantial variation in policy design highlights the need for evidence-informed guidance. Methods: We reviewed existing fragrance-free policies across multiple settings and evaluated key elements related to definitions, scope, implementation, enforcement, accommodation provisions, and accessibility. Findings were synthesized using a best-practice framework approach to identify policy components associated with clarity, enforceability, feasibility, and inclusivity, which were subsequently integrated into an evidence-informed model fragrance-free policy. Results: Several core elements were consistently associated with effective fragrance-free policies, including clear definitions, comprehensive policy scope, institutional accountability, communication and education strategies, enforcement mechanisms, accommodation pathways, source control measures, engineering controls, and ongoing monitoring and evaluation. These findings informed the development of an evidence-informed fragrance-free policy framework. Conclusion: The resulting evidence-informed framework provides a practical approach to reducing fragrance-related exposures, improving IAQ, and enhancing accessibility for individuals with multiple chemical sensitivity and fragrance sensitivities. Successful implementation of the proposed fragrance-free policy framework may support organizations to create healthier and more inclusive indoor environments.